This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Global Pharmaceutical Regulatory Affairs Summit
22-24 October 2024
Sheraton Brussels Airport, BrusselsHybrid Event

David Donne PhD
Vice President and Oncology Regulatory Affairs Group 2 at Bayer


Dr David Donne works as VP, Oncology Regulatory Strategy and In Vitro Diagnostics overseeing regulatory strategy and submissions for immuno-oncology and precision oncology projects and IVD/CDx at Bayer Oncology. Previously David worked at GSK, J&J, and Bristol-Myers Squibb in regulatory and research functions. With 25 years of pharmaceutical industry experience, he has a record of successfully leading multiple marketing application approvals in global markets including US, EU, Japan and China. David is a member of BIO CDx Task Force and PhRMA China RA Working Group.

Agenda Sessions

  • Multi-Stakeholder Perspective: Preparing a Global Submission